Laser Thermotherapy with ECHOLASER

Home Laser Thermotherapy with ECHOLASER

ELESTA ECHOLASER

ECHOLASER first and only offers the chance to carry out ultrasound-guided micro-invasive Thermotherapy treatments.
ECHOLASER Thermotherapy is a micro-invasive procedure that uses the laser light transmitted by the applicators (optical fibres) for a few minutes, which causes heating of the targeted tissue and its irreversible “in situ” damage, therefore without the need to excise it.

ECHOLASER Thermotherapy is the first and only integrated system that meets diagnosis and treatment demands (Ultrasound and Laser), consisting of an ultrasound and a multi-source laser (up to 4 sources). Thanks to the ultrasound it is possible to diagnose tumours as well as to monitor in real time the correct positioning of the laser light applicators and the effective extension of the damage caused to the tumour lesion.
The intrinsic features of Laser (coherence, collimation and monochromaticity) and the penetration method of the laser into the tissues (depending on the wavelength) make Laser Thermotherapy a successful choice.
This is all thanks to the combined action of the rise in local temperature and the exposure time. The interaction of the laser radiation with a 1064nm wavelength (within the range of the therapeutic window) provided by ECHOLASER is excellent, offering low radiation absorption and excellent penetration of the light. The laser light is conveyed by the source to the tissues through extremely flexible quartz optical fibres with a small diameter (300-micron) and a flat tip, which are inserted percutaneously by fine needles (21 Gauge- 800 microns)-thus ECHOLASER introduces the concept of micro-invasiveness thanks to the use of very small gauge applicators (<0.8mm), which makes this the best approach in a-traumatic terms, as well as the concept of the multi-applicator approach which offers the possibility of treating lesions with a much broader size range.

Advantages of Thermotherapy with ECHOLASER:

  • Laser is able to deliver energy in a precise and confined manner;
  • Laser produces predictable, precise and controlled thermal damage;
  • There is minimum dispersion of the laser energy in the tissues differing from the ablation target (which allows for treating selected volumes in critical zones);
  • The laser energy is well tolerated by the body (with a very low risk of complications).
  • Thermal destruction of the lesion “in situ”
  • Preservation of the organ and the healthy tissue
  • Micro-invasive approach (thanks to the extremely fine needles)
  • No need for a general anaesthesia
  • Brief duration of treatment (few minutes)
  • No signs or scars on the body
  • No or reduced post-op pain
  • No or reduced hospitalisation
  • Fast recovery times

Thermotherapy with ECHOLASER allows Multi-fiber Approach:

If required by the size or shape of the lesion to be treated, it is also possible to use a multi-fibre approach. The transmission of the laser energy by the fibres takes place simultaneously and thanks to a synergic coalescence action, large volumes of coagulative necrosis can be obtained with perfect control of the borders, even in larger lesions.

  • Possibility of treating lesions with a very wide size range (<1 cm with one fibre and up to 5 cm with FOUR fibres);
  • Possibility of adapting the treatment to the shape and position of the lesion;
  • Possibility of treating lesions in high risk position (due to close vicinity to vital structures);
  • Positioning of the needles with less trauma for the organ, also with the possibility of multiple repositioning actions.

Thermotherapy with ECHOLASER allows Ultrasound monitoring of the treatment

Ultrasound guidance enables real-time positioning of several needles in a safe and rapid manner, thereby reducing the operating times (with less stress for the patient, more economical treatments, and a greater number of patients treated).

Thermotherapy with ECHOLASER provides Micro-invasive technique with fine needles

The technique with very fine needles (<0.8mm) is completely a-traumatic and very well tolerated by the patient, ensuring fewer complications and side effects, less risk of infection and bleeding, rapid recovery times and excellent aesthetic results without the need for anaesthesia.
Thanks to these features, ECHOLASER is able to carry out thermotherapy in the sector of the micro-invasive methods.

Thermotherapy with ECHOLASER uses Patented Disposable Optical Fibre Kit

The disposable optical fibre Kit contains an introducer, a Chiba (21G) needle with high echogenicity, and a flat-tip optical fibre. The disposable optical fibre Kit, which is specific for each type of tissue depending on its location, has a colour code to help the operator to recognize it during the procedure. This Kit is patented.
Thermotherapy with ECHOLASER is equipped with

 Guiding Systems and dedicated Biopsy Software

The Guiding Systems on the ECHOLASER probes have been designed for each kind of application to help the operator when positioning several fibres inside the lesion to be treated. The dedicated Biopsy Software for Laser Thermotherapy inside the US unit displays the guidelines on the screen for each different guide in order to allow for evaluating the best positioning of the applicator in reference to the size, morphology and position of the lesion.

Thermotherapy with ECHOLASER  is supported by Planning Software for neck application (ModìLite)

The Planning Software for thyroid application makes it possible for the operator to choose the most suitable and safest among various treatment options for each specific case and to control the correct positioning of the needle once inserted in the nodule.

Why Thermotherapy?

The concept of Thermotherapy is broader than more frequently used Thermoablation. In case of malignant lesions (e.g. metastatic lymph nodes) ECHOLASER is a highly precise approach, very useful on lesions of small size or with non homogenous borders. On benign lesions (e.g. thyroid nodules or BPH), ECHOLASER induces a controlled cytoreduction which eliminates symptoms.



ELESTA MODILite®

ELESTA MODILite®

ModiILite® to treat lesions of the neck, in particular thyroid nodules  and metastatic lymph nodes

Why remove the thyroid gland in order to eliminate the symptoms of benign nodules?
A single ModìLite® treatment gives rise to a significant and persistent reduction in the volume of the thyroid nodule and improves the local symptoms without any changes to the thyroid function.
ModìLite® is Elesta® Thermotherapy using the ECHOLASER® systems for treating lesions of the neck, in particular, benign thyroid nodules.

The name of the treatment contains in a single word the application area (the neck, “Modì” was the nickname of Tuscan painter, Amedeo Modigliani, who portrayed female subjects with very long, slim necks) and “Lite”, which on one hand refers to the lightweight and micro-invasiveness of the treatment, and on the other, the therapeutic source (Light, therefore Laser).
The name ModìLite® allows for differentiating the procedure performed with ECHOLASER® (micro-invasiveness and multi-fibre approach in a single system) from the other thermal ablation techniques.

When ModiLite® is used?

ModìLite® is indicated for those who have one or more benign solid thyroid nodules which are large enough to create aesthetic damage or local compression symptoms, or for those who prefer not to undergo surgery.
ModìLite® is also a safe and effective treatment for subjects who, due to critical medical conditions, are not able to undergo surgery.
Despite focusing on treatment of benign solid thyroid nodules, Modìlite® is also effective for malignant neck lesions such as metastatic lymph nodes. With this application, the treatment is radical, obtaining complete ablation of the lesion.

ModiLite® features

Modìlite® consists of the percutaneous insertion of optical fibres (1 or 2 depending on the size of the nodule), and the delivery of laser energy for several minutes which causes the heating of the tissues until they are destroyed. Subsequently, the progressive reduction of the volume of the thyroid nodule (reduction of at least > 50% compared to the basal volume at the one-year follow-up) induced by the natural reduction mechanisms of the necrotic tissues of the human body leads to the disappearance of the compressive symptoms and aesthetic damage to the neck.
The planning of the treatment, the insertion of the needles and the monitoring are all carried out under ultrasound guidance. In order to facilitate the insertion manoeuvre and plan the best positioning of the needles in the lesion, ECHOLASER® exploits:

  • Planning Software in the ultrasound unit that allows for choosing among the various treatment possibilities, the most suitable and safest for each specific case, and for controlling the correct positioning of the needles inside the nodule.
  • Dedicated multi-applicator Guiding Systems for ultrasound probes specifically designed for the anatomical area of the thyroid, with the relative Biopsy Software that displays the guidelines on the screen;

ModiLite® advanatges

  • a reduction in the compressive symptoms and/or aesthetic damage
  • “in situ” thermal destruction with a consequent reduction of the nodule volume
  • preservation of the healthy tissue and the organ function
  • highly predictable and repeatable coagulation volume, as required in the small organs
  • use of fine, a-traumatic needles for the neck structures
  • possibility of treating patients with pace-makers (excellent electromagnetic compatibility)
  • absence of general anaesthesia (thanks to the very fine needles not even local anaesthetic is necessary)
  • short duration of the treatment (few minutes)
  • absence of scars on the neck
  • rapid recovery times
  • life-long hormone replacement therapy not necessary
  • no or insignificant post-treatment pain

ELESTA PBLite®

ELESTA PBLite®

PBLite® to treat primary and secondary malignant liver cancers

Why abandon the idea of a micro-invasive approach in case of lesions in high risk positions?
With just one PBLite® session it is possible to treat liver lesions with a very wide size range and diameters of up to 5 cm thanks to the versatility offered by the multi-fibre approach.
The localised thermal effect of PBLite® makes it the gold standard for liver lesions close to structures at risk.


The name of the treatment contains in a single word the application area (the liver, “PB” is the abbreviation of Prometheus bound, the titan who in Greek mythology was condemned to be bound to the rocks of the Caucasus while an eagle pecked at his liver each day) and “Lite”, which on one hand refers to the lightweight and micro-invasiveness of the treatment, and on the other, the therapeutic source (Light, therefore Laser).
The name PBLite® allows for differentiating the procedure with ECHOLASER® (micro-invasiveness and multi-fibre approach in a single system) from the other thermal ablation techniques.

When PBLite® is used?

PBLite® is indicated in the treatment of primitive and secondary liver cancer in the form of focal lesions.
PBLite® is also a safe and effective treatment of those who, due to critical medical conditions, are not able to undergo surgery.

PBLite® features

PBLite® consists of the percutaneous insertion of optical fibres (from 1 to 4 depending on the size of the tumour), and the delivery of laser energy for several minutes which causes the heating of the tissues until they are completely destroyed with a sufficient safety margin. The positioning of the applicators, monitoring of the treatment and verification of the effective coagulation area are all carried out under ultrasound guidance.
In order to facilitate the insertion manoeuvre, the system has dedicated multi-applicator Guiding Systems for ultrasound probes designed for the anatomical area of the liver with relative Biopsy Software that displays the guidelines on the screen.
As these are malignant tumours, the objective of the treatment is complete ablation of the lesion and subsequent absence of post-treatment local relapses and a net increase in the long-term survival probabilities (5 years).

PBLite® advanatges

  • a complete ablation with a sufficient safety margin
  •  “in situ” thermal destruction
  • a preservation of the healthy tissue and the organ function
  • highly predictable and repeatable coagulation volume as required for the safety margin
  • localized thermal effect in the target volume only, which makes the treatment possible close to sites at risk
  • use of fine, a-traumatic needles for liver organ
  • possibility of treating patients with pace-makers (excellent electromagnetic compatibility)
  • absence of general anesthesia
  • short duration of the treatment (few minutes)
  • rapid recovery times
  • no or insignificant post-treatment pain
  • brief hospitalization
  • bridging therapy for organ transplants

ELESTA SORACTELite®

ELESTA SORACTELite®

SORACTELite® to treat urinary system disorders (lesions), in particular Benign Prostatic Hyperplasia (BPH)

Why carry out aggressive surgery on the prostate to overcome the symptoms of PBH?
With just one SORACTELite® session it is possible to have a significant and persistent reduction in the volume of the prostatic gland and disappearance of the local symptoms, without changing the physiology of the prostatic gland.

The name of the treatment contains in a single word a connection with urologic application (“Soracte” is the name of an Italian mountain (also named in the incipit of an Horace Poem),  where there was a monastery in which the monk Nonnoso, canonized, is considered the protector of people with kidney disease) and “Lite”, which on one hand refers to the lightweight and micro-invasiveness of the treatment, and on the other, the therapeutic source (Light, therefore Laser).
The name SORACTELite® allows for differentiating the procedure with ECHOLASER® (micro-invasiveness and multi-fibre approach in a single system) from the other thermal ablation techniques

When SORACTELite® is used?

SORACTELite® is indicated in the case of patients suffering from Benign Prostatic Hyperplasia, a disease in which the volumetric increase in the prostate gland generates a compression effect at the level of the bladder floor and the urethral canal, and also in the case of subjects who choose not to undergo surgical treatment.
When you hear the word laser in urology, you instantly may think of surgical lasers, like the green laser. These lasers are an important advancement for endoscopic, transurethral surgery of the prostate. However, SORACTELite® has got nothing to do with surgical lasers; in fact, it differs in:
wavelength and power (our laser is not visible as opposed to green),

  • its mode of action (cytoreduction vs surgical vaporization), and lastly and most importantly
  • SORACTELite® is performed in a truly microinvasive approach (transperineal vs transurethral).

SORACTELite® represents true innovation for BPH treatment

Despite focusing mainly on the treatment of Benign Prostatic Hyperplasia (BPH), SORACTELite® is also effective for prostate cancer that is not clinically relevant combined with active surveillance and post-prostatectomy relapse and for kidney cancer.

SORACTELite® features

SORACTELite®  treatment consists of the percutaneous insertion of optical fibres (one or two fibres per lobe depending on the basal volume of the prostatic gland) via transperineal access, and the delivery of laser energy for several minutes which causes the heating of the tissues until they are destroyed, followed by a progressive reduction in the volume of the prostatic lobe (a reduction of at least 40% compared to the basal volume at the one-year follow-up) and subsequent disappearance of the symptoms. The planning of the treatment, the insertion of the needles and the monitoring are all carried out under ultrasound guidance. In order to facilitate the insertion manoeuvre, the system has a dedicated multi-applicator Guiding System for transrectal ultrasound probe with relative Biopsy Software that displays the guidelines on the screen.

SORACTELite® advantages

  •  resolution of symptoms
  • “in situ” thermal damage with consequent reduction of the prostatic lobe
  • preservation of the healthy tissue and the organ function
  • highly predictable and repeatable coagulation volume
  • use of fine, a-traumatic needles with transperineal approach
  • absence of general anaesthesia
  • short duration of the treatment (few minutes)
  • rapid recovery times
  • no or insignificant post-treatment pain
  • absence of erectile dysfunction or complications linked to the reproductive organs

WE’D LIKE TO SHARE WITH YOU OUR BEST PRODUCTS
A Start TO END HEALTH CARE Solutions

Contact Us